Inhibitory effect of CC chemokine ligand 23 (CCL23)/ transcription factor activating enhancer binding protein 4 (TFAP4) on cell proliferation, invasion and angiogenesis in hepatocellular carcinoma

References

• Villanueva A, Longo DL. Hepatocellular carcinoma. N Engl J Med. 2019 Apr 11;380(15):1450–1462.
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589–604.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016 Mar-Apr;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018 Mar 31;391(10127):1301–1314.
   PubMed Web of Science ®Google Scholar
• Greten TF, Lai CW, Li G, et al. Targeted and immune-based therapies for hepatocellular carcinoma. Gastroenterology. 2019 Jan;156(2):510–524.
   PubMed Web of Science ®Google Scholar
• Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019 Jan;156(2):477–491 e1.
   PubMed Web of Science ®Google Scholar
• Ko TM, Kuo HC, Chang JS, et al. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease. Circ Res. 2015 Feb 27;116(5):876–883.
   PubMed Web of Science ®Google Scholar
• Babu H, Ambikan AT, Gabriel EE, et al. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Front Immunol. 2019;10:1965.
   PubMed Web of Science ®Google Scholar
• Youn BS, Zhang SM, Broxmeyer HE, et al. Characterization of CKbeta8 and CKbeta8-1: two alternatively spliced forms of human beta-chemokine, chemoattractants for neutrophils, monocytes, and lymphocytes, and potent agonists at CC chemokine receptor 1. Blood. 1998 May 1;91(9):3118–3126.
   PubMed Web of Science ®Google Scholar
• Simats A, Garcia-Berrocoso T, Penalba A, et al. CCL23: a new CC chemokine involved in human brain damage. J Intern Med. 2018 May;283(5):461–475.
   PubMed Web of Science ®Google Scholar
• Bonaventura A, Montecucco F. CCL23 is a promising biomarker of injury in patients with ischaemic stroke. J Intern Med. 2018 May;283(5):476–478.
   PubMed Web of Science ®Google Scholar
• Faura J, Bustamante A, Penalba A, et al. CCL23: a chemokine associated with progression from mild cognitive impairment to Alzheimer’s disease. J Alzheimers Dis. 2020;73(4):1585–1595.
   PubMed Web of Science ®Google Scholar
• Han KY, Kim CW, Lee TH, et al. CCL23 up-regulates expression of KDR/Flk-1 and potentiates VEGF-induced proliferation and migration of human endothelial cells. Biochem Biophys Res Commun. 2009 Apr 24;382(1):124–128.
   PubMed Web of Science ®Google Scholar
• Lim W, Bae H, Bazer FW, et al. C-C motif chemokine ligand 23 abolishes ER stress- and LPS-induced reduction in proliferation of bovine endometrial epithelial cells. J Cell Physiol. 2018 Apr;233(4):3529–3539.
   PubMed Web of Science ®Google Scholar
• Krishnan V, Tallapragada S, Schaar B, et al. Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1. Commun Biol. 2020 Sep 22;3(1):524.
   PubMed Web of Science ®Google Scholar
• Lu J, Yang Y, Yu P, et al. [Bioinformatics analysis and significance of expression of CC chemokine ligand 23 (CCL23) in hepatocellular carcinoma]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019 Oct;35(10):903–909.
   PubMedGoogle Scholar
• Jones S. An overview of the basic helix-loop-helix proteins. Genome Biol. 2004;5(6):226.
   PubMed Web of Science ®Google Scholar
• Huang T, Chen QF, Chang BY, et al. TFAP4 promotes hepatocellular carcinoma invasion and metastasis via activating the PI3K/AKT signaling pathway. Dis Markers. 2019;2019:7129214.
   PubMed Web of Science ®Google Scholar
• Song J, Xie C, Jiang L, et al. Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/beta-catenin pathway in hepatocellular carcinoma. Theranostics. 2018;8(13):3571–3583.
   PubMed Web of Science ®Google Scholar
• Barretina J, Caponigro G, Stransky N, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012 Mar 28;483(7391):603–607.
   PubMed Web of Science ®Google Scholar
• Nusinow DP, Szpyt J, Ghandi M, et al. Quantitative proteomics of the Cancer Cell Line Encyclopedia. Cell. 2020 Jan 23;180(2):387–402.e16.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021 Jan 8;49(D1):D605–d612.
   PubMed Web of Science ®Google Scholar
• Nishina S, Yamauchi A, Kawaguchi T, et al. Dipeptidyl peptidase 4 inhibitors reduce hepatocellular carcinoma by activating lymphocyte chemotaxis in mice. Cell Mol Gastroenterol Hepatol. 2019;7(1):115–134.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001 Dec;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Guo W, Li H, Liu H, et al. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway. Oncol Rep. 2019 Sep;42(3):1075–1089.
   PubMed Web of Science ®Google Scholar
• Wang Z, Nie Z, Chen W, et al. RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation. Neoplasia (New York, NY). 2013 Sep;15(9):1028–1035.
   PubMed Web of Science ®Google Scholar
• Cao C, Zhong Q, Lu L, et al. Long noncoding RNA MSC-AS1 promotes hepatocellular carcinoma oncogenesis via inducing the expression of phosphoglycerate kinase 1. Cancer Med. 2020 Jul;9(14):5174–5184.
   PubMed Web of Science ®Google Scholar
• Liu M, Zhong YB, Shao J, et al. Tumor-associated macrophages promote human hepatoma Huh-7 cell migration and invasion through the Gli2/IGF-II/ERK1/2 axis by secreting TGF-β1. Cancer Biol Ther. 2020 Nov 1;21(11):1041–1050.
   PubMed Web of Science ®Google Scholar
• Zhang S, Tian R, Bei C, et al. Down-regulated CMTM2 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Onco Targets Ther. 2020;13:5731–5741.
   PubMedGoogle Scholar
• Fu C, An N, Liu J, et al. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells. J Biol Chem. 2020 May 15;295(20):7060–7074.
   PubMed Web of Science ®Google Scholar
• Mishra P, Pandey CM, Singh U, et al. Selection of appropriate statistical methods for data analysis. Ann Card Anaesth. 2019 Jul-Sep;22(3):297–301.
   PubMed Web of Science ®Google Scholar
• McHugh ML. Multiple comparison analysis testing in ANOVA. Biochem Med (Zagreb). 2011;21(3):203–209.
   PubMed Web of Science ®Google Scholar
• Xu S, Xu H, Wang W, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019 Sep 14;17(1):309.
   PubMed Web of Science ®Google Scholar
• Ahir BK, Engelhard HH, Lakka SS. Tumor development and angiogenesis in adult brain tumor: glioblastoma. Mol Neurobiol. 2020 May;57(5):2461–2478.
   PubMed Web of Science ®Google Scholar
• Chiew GGY, Fu A, Perng Low K, et al. Physical supports from liver cancer cells are essential for differentiation and remodeling of endothelial cells in a HepG2-HUVEC co-culture model. Sci Rep. 2015 Jun 8;5:10801.
   PubMed Web of Science ®Google Scholar
• Yanaba K, Yoshizaki A, Muroi E, et al. Serum CCL23 levels are increased in patients with systemic sclerosis. Arch Dermatol Res. 2011 Jan;303(1):29–34.
   PubMed Web of Science ®Google Scholar
• Poposki JA, Uzzaman A, Nagarkar DR, et al. Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2011 Jul;128(1):73–81 e4.
   PubMed Web of Science ®Google Scholar
• Wu H, Liu X, Gong P, et al. Elevated TFAP4 regulates lncRNA TRERNA1 to promote cell migration and invasion in gastric cancer. Oncol Rep. 2018 Aug;40(2):923–931.
   PubMed Web of Science ®Google Scholar
• Arruda-Silva F, Bianchetto-Aguilera F, Gasperini S, et al. Human neutrophils produce CCL23 in response to various TLR-Agonists and TNFα. Front Cell Infect Microbiol. 2017;7:176.
   PubMed Web of Science ®Google Scholar
• Zhu M, Xu W, Wei C, et al. CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis. Cell Death Dis. 2019 Oct 22;10(11):796.
   PubMedGoogle Scholar
• Aikman B, de Almeida A, Meier-Menches SM, et al. Aquaporins in cancer development: opportunities for bioinorganic chemistry to contribute novel chemical probes and therapeutic agents. Metallomics. 2018 May 23;10(5):696–712.
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhou L, Lv D, et al. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression. J Hematol Oncol. 2019 May 29;12(1):53.
   PubMedGoogle Scholar
• Bruserud O, Ryningen A, Olsnes AM, et al. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica. 2007 Mar;92(3):332–341.
   PubMed Web of Science ®Google Scholar
• Makikallio K, Kaukola T, Tuimala J, et al. Umbilical artery chemokine CCL16 is associated with preterm preeclampsia and fetal growth restriction. Cytokine. 2012 Nov;60(2):377–384.
   PubMed Web of Science ®Google Scholar
• Korbecki J, Kojder K, Simińska D, et al. CC Chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4. Int J Mol Sci. 2020 Nov 9;21(21):8412.
   PubMed Web of Science ®Google Scholar